SCHEMBL2279733

SCHEMBL2279733

Cc1nc2cnc3c(ccn3S(=O)(=O)c3ccccc3)c2n1C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 3/20 0.60
JAK2 O60674 2/20 0.60
HTR6 P50406 6/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
HTT P42858 1/20 0.41
POLB P06746 1/20 0.40
ALDH1A1 P00352 2/20 0.40
HTR2A P28223 1/20 0.40
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
AKT1 P31749 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
JAK3 P52333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2224293 0.89 JAK1 (0.46) JAK1JAK2HTR6POLBALDH1A1
SCHEMBL2277491 0.88 JAK2 (0.46) JAK1JAK2HTR6SMN1; SMN2POLB
SCHEMBL2277746 0.88 JAK1 (0.45) JAK1JAK2HTR6SMN1; SMN2POLB
SCHEMBL2280024 0.88 JAK1 (0.46) JAK1JAK2HTR6SMN1; SMN2JAK3
SCHEMBL12384876 0.88 JAK1 (0.46) JAK1JAK2HTR6SMN1; SMN2ALDH1A1
SCHEMBL2225086 0.88 JAK2 (0.46) JAK1JAK2HTR6ALDH1A1HTR2A
SCHEMBL2280608 0.87 RAF1 (0.46) JAK1JAK2HTR6HTTJAK3
SCHEMBL2276629 0.87 JAK1 (0.45) JAK1JAK2HTR6POLBHTR2A
SCHEMBL2274893 0.87 JAK1 (0.45) JAK1JAK2HTR6POLBALDH1A1
SCHEMBL9952493 0.87 HTR6 (0.43) JAK1JAK2HTR6POLBHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523957-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. Hoffmann-La Roche AG (CH) 2012-11-21 EP disclosed
WO-2011086053-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2011-07-21 WO disclosed